Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review

Overview

Journal Clin Colorectal Cancer

Publisher Elsevier

Specialties Gastroenterology
Oncology

Date 2018 Jan 8

PMID 29306522

Citations 6

Authors

Angel Mier Hicks

Antonio DeRosa

Micheal Raj

Richard Do

Kenneth H Yu

Maeve A Lowery

Anna Varghese

Eileen M OReilly

Affiliations

Soon will be listed here.

Abstract

Within gastrointestinal malignancies, primary hepatocellular carcinoma and pancreatic ductal adenocarcinoma (PDAC) are frequently associated with visceral thromboses (VT). Thrombus formation in the portal (PVT), mesenteric (MVT), or splenic vein (SVT) system leads to portal hypertension and intestinal ischemia. VT in PDAC may convey a risk of increased distal thrombosis and poses therapeutic uncertainty regarding the role of anticoagulation. An increasing number of reports describe VT associated with PDAC. It is possible that early diagnosis of these events may help reduce morbidity and speculatively improve oncologic outcomes. To perform a systematic review to study PVT, MVT, and SVT associated with PDAC, and to provide a comprehensive review. Medline/PubMed, Embase, Web of Science, Scopus, and the Cochrane Library. Data Extraction and Assessment: Two blinded independent observers extracted and assessed the studies for diagnosis of PVT, MVT, and SVT in PDAC. Studies were restricted to English-language literature published between 2007 and 2016. Eleven articles were identified. Five case reports and 7 retrospective studies were found, with a total of 127 patients meeting the inclusion criteria. The mean age at diagnosis was 64 years. PVT was found in 35% (n = 46), SVT in 52% (n = 65), and MVT in 13% (n = 15). Mean follow-up time was 26 months. Only 3 of the selected articles studied the impact of anticoagulation in VT. All patients with nonvisceral thrombosis (eg, deep-vein thrombosis, pulmonary emboli) were therapeutically treated; in contrast, patients with VT only rarely received treatment. VT in PDAC is a frequent finding at diagnosis or during disease progression. Evidence to guide treatment choices is limited, and current management is based on inferred experience from nononcologic settings. Anticoagulation appears to be safe in VT, with most of the large studies recommending a careful assessment for patients at a high risk of bleeding.

Citing Articles

Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases.

Borbely R, Teutsch B, Hegyi P United European Gastroenterol J. 2025; 13(1):86-96.

PMID: 39743752 PMC: 11866318. DOI: 10.1002/ueg2.12744.

Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study.

Riescher-Tuczkiewicz A, Gregory J, Bert F, Zappa M, Pellat A, Lalande V Ther Adv Med Oncol. 2024; 16:17588359241258440.

PMID: 38845791 PMC: 11155326. DOI: 10.1177/17588359241258440.

Successful Multimodal Treatment of Pancreatic Cancer With Extensive Superior Mesenteric Vein Thrombosis Utilizing Chemotherapy Combined With Direct Oral Anticoagulant.

Harada K, Fujikawa T, Matsuoka T, Uemoto Y, Emoto N Cureus. 2024; 16(2):e53657.

PMID: 38449979 PMC: 10917603. DOI: 10.7759/cureus.53657.

Inferior Vena Cava Tumor Thrombus Secondary to Mucinous Adenocarcinoma of the Stomach.

Tuck N, Kamran S Cureus. 2021; 13(7):e16543.

PMID: 34466306 PMC: 8396413. DOI: 10.7759/cureus.16543.

Venous and Arterial Thromboembolism in Patients With Cancer: : State-of-the-Art Review.

Gervaso L, Dave H, Khorana A JACC CardioOncol. 2021; 3(2):173-190.

PMID: 34396323 PMC: 8352228. DOI: 10.1016/j.jaccao.2021.03.001.

References

Dumitrascu D, Suciu O, Grad C, Gheban D . Thrombotic complications of pancreatic cancer: classical knowledge revisited. Dig Dis. 2010; 28(2):350-4. DOI: 10.1159/000319413. View

Carrier M, Khorana A, Zwicker J, Noble S, Lee A . Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2013; 11(9):1760-5. DOI: 10.1111/jth.12338. View

Jamieson N . Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation. 2000; 69(9):1772-4. DOI: 10.1097/00007890-200005150-00006. View

Douma R, Kok M, Verberne L, Kamphuisen P, Buller H . Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res. 2010; 125(6):e306-9. DOI: 10.1016/j.thromres.2010.02.010. View

Wharin C, Tagalakis V . Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. Blood Rev. 2013; 28(1):1-8. DOI: 10.1016/j.blre.2013.11.001. View

DeLeve L, Valla D, Garcia-Tsao G . Vascular disorders of the liver. Hepatology. 2009; 49(5):1729-64. PMC: 6697263. DOI: 10.1002/hep.22772. View

Parikh S, Shah R, Kapoor P . Portal vein thrombosis. Am J Med. 2010; 123(2):111-9. DOI: 10.1016/j.amjmed.2009.05.023. View

Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S . Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis. Pancreatology. 2014; 14(6):524-9. DOI: 10.1016/j.pan.2014.09.006. View

Morasch M, Ebaugh J, Chiou A, Matsumura J, Pearce W, Yao J . Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg. 2001; 34(4):680-4. DOI: 10.1067/mva.2001.116965. View

10.

Valla D . Splanchnic Vein Thrombosis. Semin Thromb Hemost. 2015; 41(5):494-502. DOI: 10.1055/s-0035-1550439. View

11.

Tublin M, Dodd 3rd G, BARON R . Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997; 168(3):719-23. DOI: 10.2214/ajr.168.3.9057522. View

12.

Belli A, Jennings C, Nakielny R . Splenic and portal venous thrombosis: a vascular complication of pancreatic disease demonstrated on computed tomography. Clin Radiol. 1990; 41(1):13-6. DOI: 10.1016/s0009-9260(05)80924-9. View

13.

Yamato H, Kawakami H, Kuwatani M, Shinada K, Kondo S, Kubota K . Pancreatic carcinoma associated with portal vein tumor thrombus: three case reports. Intern Med. 2009; 48(3):143-50. DOI: 10.2169/internalmedicine.48.1049. View

14.

Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N . Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985; 89(2):279-86. DOI: 10.1016/0016-5085(85)90327-0. View

15.

Afsar C, Gunaldi M, Kum P, Sahin B, Erkisi M, Kara I . Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev. 2014; 15(21):9143-6. DOI: 10.7314/apjcp.2014.15.21.9143. View

16.

Khorana A, Carrier M, Garcia D, Lee A . Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis. 2016; 41(1):81-91. PMC: 4715852. DOI: 10.1007/s11239-015-1313-4. View

17.

Belli L, Romani F, Sansalone C, Aseni P, Rondinara G . Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg. 1986; 203(3):286-91. PMC: 1251092. DOI: 10.1097/00000658-198603000-00012. View

18.

Ageno W, Riva N, Schulman S, Bang S, Sartori M, Grandone E . Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry. Semin Thromb Hemost. 2014; 40(1):99-105. DOI: 10.1055/s-0033-1363473. View

19.

Dedania N, Agrawal N, Winter J, Koniaris L, Rosato E, Sauter P . Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer. J Gastrointest Surg. 2013; 17(8):1392-8. DOI: 10.1007/s11605-013-2260-z. View

20.

Acosta S, Ogren M, Sternby N, Bergqvist D, Bjorck M . Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg. 2005; 41(1):59-63. DOI: 10.1016/j.jvs.2004.10.011. View